Package 0548-8352-02

{"route": ["NASAL"], "spl_id": "8d3aa4dd-737c-49b4-af0d-fe95e3bee54d", "openfda": {"nui": ["N0000190852", "N0000190853", "N0000009340", "N0000009345", "N0000008636", "N0000008635", "N0000008652"], "unii": ["76LA80IG2G"], "rxcui": ["2180666", "2180671"], "spl_set_id": ["f1f5df9b-872f-44e5-a18f-f0b68e7e9254"], "pharm_class_pe": ["Increased Gluconeogenesis [PE]", "Increased Glycogenolysis [PE]", "Decreased GI Smooth Muscle Tone [PE]", "Decreased GI Motility [PE]", "Decreased Glycolysis [PE]"], "pharm_class_epc": ["Antihypoglycemic Agent [EPC]", "Gastrointestinal Motility Inhibitor [EPC]"], "manufacturer_name": ["Amphastar Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 TUBE in 1 CARTON (0548-8352-02)  / 1 BOTTLE, UNIT-DOSE in 1 TUBE / 1 POWDER in 1 BOTTLE, UNIT-DOSE", "package_ndc": "0548-8352-02", "marketing_start_date": "20240207"}], "brand_name": "Baqsimi", "product_id": "0548-8352_8d3aa4dd-737c-49b4-af0d-fe95e3bee54d", "dosage_form": "POWDER", "pharm_class": ["Antihypoglycemic Agent [EPC]", "Decreased GI Motility [PE]", "Decreased GI Smooth Muscle Tone [PE]", "Decreased Glycolysis [PE]", "Gastrointestinal Motility Inhibitor [EPC]", "Increased Gluconeogenesis [PE]", "Increased Glycogenolysis [PE]"], "product_ndc": "0548-8352", "generic_name": "glucagon", "labeler_name": "Amphastar Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Baqsimi", "active_ingredients": [{"name": "GLUCAGON", "strength": "3 mg/1"}], "application_number": "NDA210134", "marketing_category": "NDA", "marketing_start_date": "20190724", "listing_expiration_date": "20261231"}